Technological advances are expected in the next few years for the management of diabetes, with improvements...

How obesity management has shifted toward long-term health outcomes instead of merely achieving short-term weight loss...

GLP-1 agonists can help patients with obesity achieve significant weight loss and associated health benefits We...

There are approximately 270,000 people living with type 2 diabetes in Ireland today. In 2023, a...

Treatment considerations in different types of diabetes Diabetes is a metabolic disease characterised by elevated blood...

The HSE has launched an updated clinical guideline for type 1 diabetes and an updated model...

Obesity is described by the HSE as a chronic, complex, and progressive neuroendocrine disease, and is...

Diabetic retinopathy (DR) is the commonest microvascular complication of diabetes mellitus (DM). The retina is vulnerable...

Preliminary indications from ongoing Irish research are that patient preferences could play a significant role in...

A look at current and future pharmacology therapies for type 2 diabetes and pre-diabetes. Type 2...

In this issue, comprehensive clinical articles, the latest research updates, and two CPD modules covering type...

The American Diabetes Association’s 2023 Standards of Care reflect changes in technology...